Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Rheumatoid Arthritis

Free Subscription Articles published in Clin Rheumatol Retrieve available abstracts of 280 articles: HTML format Text format

Single Articles

August 2019
1. HUANG S, He X, Doyle TJ, Zaccardelli A, et al
   Association of rheumatoid arthritis-related autoantibodies with pulmonary function test abnormalities in a rheumatoid arthritis registry.
   Clin Rheumatol. 2019 Aug 13. pii: 10.1007/s10067-019-04733.
   PubMed     Text format     Abstract available
   
   
   
2. MORI S, Ueki Y
   Outcomes of dose reduction, withdrawal, and restart of tofacitinib in patients with rheumatoid arthritis: a prospective observational study.
   Clin Rheumatol. 2019 Aug 9. pii: 10.1007/s10067-019-04721.
   PubMed     Text format     Abstract available
   
   
   
3. GOGGINS MR, Conway R, Durcan LJ, Johnston C, et al
   High prevalence of abnormalities on chest radiography in rheumatoid arthritis.
   Clin Rheumatol. 2019 Aug 8. pii: 10.1007/s10067-019-04717.
   PubMed     Text format     Abstract available
   
   
   
4. EDWARDS CJ, Monnet J, Ullmann M, Vlachos P, et al
   Safety of adalimumab biosimilar MSB11022 (acetate-buffered formulation) in patients with moderately-to-severely active rheumatoid arthritis.
   Clin Rheumatol. 2019 Aug 8. pii: 10.1007/s10067-019-04679.
   PubMed     Text format     Abstract available
   
   
   
5. ALIA F, Rim BS, Miladi S, Ouenniche K, et al
   Comparison of sexual function in Tunisian women with rheumatoid arthritis and healthy controls.
   Clin Rheumatol. 2019 Aug 7. pii: 10.1007/s10067-019-04726.
   PubMed     Text format     Abstract available
   
   
   
6. NACHVAK SM, Alipour B, Mahdavi AM, Aghdashi MA, et al
   Effects of coenzyme Q10 supplementation on matrix metalloproteinases and DAS-28 in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled clinical trial.
   Clin Rheumatol. 2019 Aug 7. pii: 10.1007/s10067-019-04723.
   PubMed     Text format     Abstract available
   
   
   
7. ZAFARI P, Zarifian A, Alizadeh-Navaei R, Taghadosi M, et al
   Asymmetric and symmetric dimethylarginine concentration as an indicator of cardiovascular diseases in rheumatoid arthritis patients: a systematic review and meta-analysis of case-control studies.
   Clin Rheumatol. 2019 Aug 3. pii: 10.1007/s10067-019-04713.
   PubMed     Text format     Abstract available
   
   
   
8. YOSHII I, Chijiwa T, Sawada N
   Validity of adopting a Health Assessment Questionnaire Disability Index less than 0.5 as a target in elderly rheumatoid arthritis patients.
   Clin Rheumatol. 2019 Aug 1. pii: 10.1007/s10067-019-04692.
   PubMed     Text format     Abstract available
   
   
   
9. TAVAKOLPOUR S, Alesaeidi S, Darvishi M, GhasemiAdl M, et al
   A comprehensive review of rituximab therapy in rheumatoid arthritis patients.
   Clin Rheumatol. 2019 Aug 1. pii: 10.1007/s10067-019-04699.
   PubMed     Text format     Abstract available
   
   
   July 2019
10. SHADICK NA, Gerlanc NM, Frits ML, Stolshek BS, et al
    The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.
    Clin Rheumatol. 2019 Jul 29. pii: 10.1007/s10067-019-04649.
    PubMed     Text format     Abstract available
    
    
    
11. GADEHOLT O, Hausotter K, Eberle H, Klink T, et al
    Correction to: Differing X-ray patterns in seronegative and seropositive rheumatoid arthritis.
    Clin Rheumatol. 2019 Jul 26. pii: 10.1007/s10067-019-04703.
    PubMed     Text format     Abstract available
    
    
    
12. MOHARAMOGHLI M, Hassan-Zadeh V, Dolatshahi E, Alizadeh Z, et al
    The expression of GAS5, THRIL, and RMRP lncRNAs is increased in T cells of patients with rheumatoid arthritis.
    Clin Rheumatol. 2019 Jul 25. pii: 10.1007/s10067-019-04694.
    PubMed     Text format     Abstract available
    
    
    
13. REYES-PEREZ IV, Sanchez-Hernandez PE, Munoz-Valle JF, Martinez-Bonilla GE, et al
    Cytokines (IL-15, IL-21, and IFN-gamma) in rheumatoid arthritis: association with positivity to autoantibodies (RF, anti-CCP, anti-MCV, and anti-PADI4) and clinical activity.
    Clin Rheumatol. 2019 Jul 17. pii: 10.1007/s10067-019-04681.
    PubMed     Text format     Abstract available
    
    
    
14. LI L, Gao S, Fu Q, Liu R, et al
    A preliminary study of lung abnormalities on HRCT in patients of rheumatoid arthritis-associated interstitial lung disease with progressive fibrosis.
    Clin Rheumatol. 2019 Jul 13. pii: 10.1007/s10067-019-04673.
    PubMed     Text format     Abstract available
    
    
    
15. ALTEN R, Feist E, Lorenz HM, Nusslein H, et al
    Abatacept retention and clinical outcomes in rheumatoid arthritis: real-world data from the German cohort of the ACTION study and a comparison with other participating countries.
    Clin Rheumatol. 2019 Jul 12. pii: 10.1007/s10067-019-04648.
    PubMed     Text format     Abstract available
    
    
    
16. YILMAZ-ONER S, Gazel U, Can M, Atagunduz P, et al
    Predictors and the optimal duration of sustained remission in rheumatoid arthritis.
    Clin Rheumatol. 2019 Jul 3. pii: 10.1007/s10067-019-04654.
    PubMed     Text format     Abstract available
    
    
    
17. MYASOEDOVA E, Crowson CS, Giblon RE, McCarthy-Fruin K, et al
    Optimization of flare management in patients with rheumatoid arthritis: results of a randomized controlled trial.
    Clin Rheumatol. 2019 Jul 1. pii: 10.1007/s10067-019-04664.
    PubMed     Text format     Abstract available
    
    
    June 2019
18. HAVIV-YADID Y, Segal Y, Dagan A, Sharif K, et al
    Mortality of patients with rheumatoid arthritis requiring intensive care: a single-center retrospective study.
    Clin Rheumatol. 2019 Jun 26. pii: 10.1007/s10067-019-04651.
    PubMed     Text format     Abstract available
    
    
    
19. VRANIC A, Pruner I, Veselinovic M, Soutari N, et al
    Assessment of hemostatic disturbances in women with established rheumatoid arthritis.
    Clin Rheumatol. 2019 Jun 17. pii: 10.1007/s10067-019-04629.
    PubMed     Text format     Abstract available
    
    
    
20. PETERSEN LE, Schuch JB, de Azeredo LA, Baptista TSA, et al
    Characterization of senescence biomarkers in rheumatoid arthritis: relevance to disease progression.
    Clin Rheumatol. 2019 Jun 11. pii: 10.1007/s10067-019-04615.
    PubMed     Text format     Abstract available
    
    
    
21. OGAWA Y, Takahashi N, Kaneko A, Hirano Y, et al
    Association between seropositivity and discontinuation of tumor necrosis factor inhibitors due to ineffectiveness in rheumatoid arthritis.
    Clin Rheumatol. 2019 Jun 10. pii: 10.1007/s10067-019-04626.
    PubMed     Text format     Abstract available
    
    
    
22. WU D, Hou SY, Zhao S, Hou LX, et al
    Meta-analysis of IL-17 inhibitors in two populations of rheumatoid arthritis patients: biologic-naive or tumor necrosis factor inhibitor inadequate responders.
    Clin Rheumatol. 2019 Jun 4. pii: 10.1007/s10067-019-04608.
    PubMed     Text format     Abstract available
    
    
    
23. TEN KLOOSTER PM, Oude Voshaar MAH, Fakhouri W, de la Torre I, et al
    Long-term clinical, functional, and cost outcomes for early rheumatoid arthritis patients who did or did not achieve early remission in a real-world treat-to-target strategy.
    Clin Rheumatol. 2019 Jun 3. pii: 10.1007/s10067-019-04600.
    PubMed     Text format     Abstract available
    
    
    
24. ELSAYED SA, Esmail MA, Ali RM, Mohafez OM, et al
    Diagnostic and prognostic value of anti-CarP antibodies in a sample of Egyptian rheumatoid arthritis patients.
    Clin Rheumatol. 2019 Jun 3. pii: 10.1007/s10067-019-04616.
    PubMed     Text format     Abstract available
    
    
    
25. GAMBOA-CARDENAS RV, Ugarte-Gil MF, Loreto M, Sacnun MP, et al
    Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort.
    Clin Rheumatol. 2019 Jun 3. pii: 10.1007/s10067-019-04618.
    PubMed     Text format     Abstract available
    
    
    May 2019
26. AN J, Nyarko E, Hamad MA
    Prevalence of comorbidities and their associations with health-related quality of life and healthcare expenditures in patients with rheumatoid arthritis.
    Clin Rheumatol. 2019 May 27. pii: 10.1007/s10067-019-04613.
    PubMed     Text format     Abstract available
    
    
    
27. OTTAR G, Katharina H, Hannes E, Thorsten K, et al
    Differing X-ray patterns in seronegative and seropositive rheumatoid arthritis.
    Clin Rheumatol. 2019 May 23. pii: 10.1007/s10067-019-04602.
    PubMed     Text format     Abstract available
    
    
    
28. ASHIRI A, Beiromvand M, Khanzadeh A
    Strongyloides stercoralis infection in a patient with rheumatoid arthritis and type 2 diabetes mellitus: a case-based review.
    Clin Rheumatol. 2019 May 23. pii: 10.1007/s10067-019-04611.
    PubMed     Text format     Abstract available
    
    
    
29. LOUTHRENOO W, Nilganuwong S, Nanagara R, Siripaitoon B, et al
    Diacerein for the treatment of rheumatoid arthritis in patients with inadequate response to methotrexate: a pilot randomized, double-blind, placebo-controlled add-on trial.
    Clin Rheumatol. 2019 May 19. pii: 10.1007/s10067-019-04587.
    PubMed     Text format     Abstract available
    
    
    
30. TAKAHASHI N, Kojima T, Kida D, Kaneko A, et al
    Concomitant methotrexate has little effect on clinical outcomes of abatacept in rheumatoid arthritis: a propensity score matching analysis.
    Clin Rheumatol. 2019 May 17. pii: 10.1007/s10067-019-04581.
    PubMed     Text format     Abstract available
    
    
    
31. ZHAO P, Miao J, Zhang K, Yu Z, et al
    CD147 participates in the activation function of circulating angiogenic T cells in patients with rheumatoid arthritis.
    Clin Rheumatol. 2019 May 14. pii: 10.1007/s10067-019-04584.
    PubMed     Text format     Abstract available
    
    
    
32. HUANG Y, Fan Y, Liu Y, Xie W, et al
    Efficacy and safety of secukinumab in active rheumatoid arthritis with an inadequate response to tumor necrosis factor inhibitors: a meta-analysis of phase III randomized controlled trials.
    Clin Rheumatol. 2019 May 14. pii: 10.1007/s10067-019-04595.
    PubMed     Text format     Abstract available
    
    
    
33. RUIZ-MEDRANO E, Espinosa-Ortega HF, Arce-Salinas CA
    The effect of concomitant hand osteoarthritis on pain and disease activity in patients with rheumatoid arthritis.
    Clin Rheumatol. 2019 May 10. pii: 10.1007/s10067-019-04574.
    PubMed     Text format     Abstract available
    
    
    
34. BATKO B, Urbanski K, Swierkot J, Wiland P, et al
    Comorbidity burden and clinical characteristics of patients with difficult-to-control rheumatoid arthritis.
    Clin Rheumatol. 2019 May 10. pii: 10.1007/s10067-019-04579.
    PubMed     Text format     Abstract available
    
    
    
35. TOMIC-SMILJANIC M, Vasiljevic D, Lucic-Tomic A, Andjelkovic N, et al
    Influence of different supplementation on platelet aggregation in patients with rheumatoid arthritis.
    Clin Rheumatol. 2019 May 10. pii: 10.1007/s10067-019-04569.
    PubMed     Text format     Abstract available
    
    
    
36. COHEN SB, Kremer JM, Dandreo KJ, Reed GW, et al
    Outcomes of infliximab dose escalation in patients with rheumatoid arthritis.
    Clin Rheumatol. 2019 May 2. pii: 10.1007/s10067-019-04543.
    PubMed     Text format     Abstract available
    
    
    
37. JOO YB, Park YJ, Park KS, Kim KJ, et al
    Association of cumulative anti-cyclic citrullinated protein antibodies with radiographic progression in patients with rheumatoid arthritis.
    Clin Rheumatol. 2019 May 2. pii: 10.1007/s10067-019-04554.
    PubMed     Text format     Abstract available
    
    
    
38. KANG JH, Xirasagar S, Lin HC, Kao PF, et al
    Correction to: Risk of adverse outcomes in patients with rheumatoid arthritis hospitalized for stroke-a cross-sectional study.
    Clin Rheumatol. 2019;38:1533.
    PubMed     Text format     Abstract available
    
    
    April 2019
39. SUH CH, Jung JY, Oh H, Boo S, et al
    Evaluation of factors affecting the levels of physical activity in patients with rheumatoid arthritis: a cross-sectional study.
    Clin Rheumatol. 2019 Apr 29. pii: 10.1007/s10067-019-04559.
    PubMed     Text format     Abstract available
    
    
    
40. LEE GY, Kim S, Choi ST, Song JS, et al
    The superb microvascular imaging is more sensitive than conventional power Doppler imaging in detection of active synovitis in patients with rheumatoid arthritis.
    Clin Rheumatol. 2019 Apr 27. pii: 10.1007/s10067-019-04550.
    PubMed     Text format     Abstract available
    
    
    
41. BYKERK VP, Ostor AJK, Alvaro-Gracia J, Pavelka K, et al
    Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice.
    Clin Rheumatol. 2019 Apr 26. pii: 10.1007/s10067-019-04535.
    PubMed     Text format     Abstract available
    
    
    
42. KRASSELT M, Baerwald C, Liebert UG, Seifert O, et al
    Humoral immunity to varicella zoster virus is altered in patients with rheumatoid arthritis.
    Clin Rheumatol. 2019 Apr 26. pii: 10.1007/s10067-019-04563.
    PubMed     Text format     Abstract available
    
    
    
43. LAMBOVA SN, Muller-Ladner U
    Capillaroscopic features of microangiopathy in rheumatoid arthritis patients with peripheral vascular syndrome.
    Clin Rheumatol. 2019 Apr 24. pii: 10.1007/s10067-019-04561.
    PubMed     Text format    
    
    
    
44. HUANG Y, Zheng S, Wang R, Tang C, et al
    CCL5 and related genes might be the potential diagnostic biomarkers for the therapeutic strategies of rheumatoid arthritis.
    Clin Rheumatol. 2019 Apr 22. pii: 10.1007/s10067-019-04533.
    PubMed     Text format     Abstract available
    
    
    
45. DE AZEVEDO BRANCO LG, Oliveira SR, Correa JD, Calderaro DC, et al
    Oral health-related quality of life among individuals with rheumatoid arthritis.
    Clin Rheumatol. 2019 Apr 19. pii: 10.1007/s10067-019-04555.
    PubMed     Text format     Abstract available
    
    
    
46. RANZA R, de la Vega MC, Laurindo IMM, Gomez MG, et al
    Changing rate of serious infections in biologic-exposed rheumatoid arthritis patients. Data from South American registries BIOBADABRASIL and BIOBADASAR.
    Clin Rheumatol. 2019 Apr 17. pii: 10.1007/s10067-019-04516.
    PubMed     Text format     Abstract available
    
    
    
47. ALTEN R, Mariette X, Lorenz HM, Nusslein H, et al
    Correction to: Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study.
    Clin Rheumatol. 2019 Apr 11. pii: 10.1007/s10067-019-04545.
    PubMed     Text format     Abstract available
    
    
    
48. ZHAO WH, Zhang LX, Liu CX, Niedermann K, et al
    Validation of the Chinese version of joint protection self-efficacy scale in patients with rheumatoid arthritis.
    Clin Rheumatol. 2019 Apr 10. pii: 10.1007/s10067-019-04510.
    PubMed     Text format     Abstract available
    
    
    
49. HERNANDEZ-DIAZ C, Sanchez-Bringas G, Ventura-Rios L, Robles-San Roman M, et al
    Ankle pain in rheumatoid arthritis: comparison of clinical and sonographic findings.
    Clin Rheumatol. 2019 Apr 2. pii: 10.1007/s10067-019-04532.
    PubMed     Text format     Abstract available
    
    
    
50. SUN W, Tian L, Jiang L, Zhang S, et al
    Sclerostin rather than Dickkopf-1 is associated with mSASSS but not with disease activity score in patients with ankylosing spondylitis.
    Clin Rheumatol. 2019;38:989-995.
    PubMed     Text format     Abstract available
    
    
    March 2019
51. QIU XJ, Zhang XL, Cai LS, Yan C, et al
    Rheumatoid arthritis and risk of anxiety: a meta-analysis of cohort studies.
    Clin Rheumatol. 2019 Mar 28. pii: 10.1007/s10067-019-04502.
    PubMed     Text format     Abstract available
    
    
    
52. ELMEDANY SH, Mohamed AE, Galil SMA
    Efficacy and safety profile of intravenous tocilizumab versus intravenous abatacept in treating female Saudi Arabian patients with active moderate-to-severe rheumatoid arthritis.
    Clin Rheumatol. 2019 Mar 26. pii: 10.1007/s10067-019-04508.
    PubMed     Text format     Abstract available
    
    
    
53. LI Y, Jiang L, Zhang Z, Li H, et al
    Clinical characteristics of rheumatoid arthritis patients with peripheral neuropathy and potential related risk factors.
    Clin Rheumatol. 2019 Mar 25. pii: 10.1007/s10067-019-04521.
    PubMed     Text format     Abstract available
    
    
    
54. NAVARRO-ZARZA JE, Munoz-Valle JF, Banos-Hernandez CJ, Parra-Rojas I, et al
    PRL -1149T allele (rs1341239) is associated with decreased risk of rheumatoid arthritis in population from southern Mexico: analysis of mRNA expression and PRL serum levels.
    Clin Rheumatol. 2019 Mar 25. pii: 10.1007/s10067-019-04517.
    PubMed     Text format     Abstract available
    
    
    
55. BAE SC, Lee YH
    Associations between paraoxonase 1 (PON1) polymorphisms and susceptibility and PON1 activity in rheumatoid arthritis patients, and comparison of PON1 activity in patients and controls: a meta-analysis.
    Clin Rheumatol. 2019 Mar 13. pii: 10.1007/s10067-019-04499.
    PubMed     Text format     Abstract available
    
    
    
56. KATCHAMART W, Narongroeknawin P, Phutthinart N, Srinonprasert V, et al
    Disease activity is associated with cognitive impairment in patients with rheumatoid arthritis.
    Clin Rheumatol. 2019 Mar 8. pii: 10.1007/s10067-019-04488.
    PubMed     Text format     Abstract available
    
    
    
57. URETEN K, Erbay H, Maras HH
    Detection of rheumatoid arthritis from hand radiographs using a convolutional neural network.
    Clin Rheumatol. 2019 Mar 8. pii: 10.1007/s10067-019-04487.
    PubMed     Text format     Abstract available
    
    
    
58. IDOLAZZI L, Zabotti A, Fassio A, Errichetti E, et al
    The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions.
    Clin Rheumatol. 2019;38:913-920.
    PubMed     Text format     Abstract available
    
    
    
59. PONIKOWSKA M, Swierkot J, Nowak B, Korman L, et al
    Autoantibody and metalloproteinase activity in early arthritis.
    Clin Rheumatol. 2019;38:827-834.
    PubMed     Text format     Abstract available
    
    
    
60. RELAS H, Kosola S
    Acceptable quality of life and low disease activity achievable among transition phase patients with rheumatic disease.
    Clin Rheumatol. 2019;38:785-791.
    PubMed     Text format     Abstract available
    
    
    
61. OZISLER C, Kaplanoglu H
    Evaluation of subclinical atherosclerosis by ultrasound radiofrequency data technology in patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2019;38:709-717.
    PubMed     Text format     Abstract available
    
    
    
62. CITERA G, Pra FD, Waimann CA, Ficco HM, et al
    Frequency of human leukocyte antigens class II-DR alleles (HLA-DRB1) in Argentinian patients with early arthritis.
    Clin Rheumatol. 2019;38:675-681.
    PubMed     Text format     Abstract available
    
    
    
63. LIU X, Li X, Li X, Li Z, et al
    The efficacy and safety of total glucosides of peony in the treatment of primary Sjogren's syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trial.
    Clin Rheumatol. 2019;38:657-664.
    PubMed     Text format     Abstract available
    
    
    February 2019
64. WANG XP, Cheng QY, Gu MM, Leng RX, et al
    Diagnostic accuracy of anti-keratin antibody for rheumatoid arthritis: a meta-analysis.
    Clin Rheumatol. 2019 Feb 27. pii: 10.1007/s10067-019-04464.
    PubMed     Text format     Abstract available
    
    
    
65. GOSSELIN BOUCHER V, Colmegna I, Gemme C, Labbe S, et al
    Correction to: Interventions to improve vaccine acceptance among rheumatoid arthritis patients: a systematic review.
    Clin Rheumatol. 2019 Feb 27. pii: 10.1007/s10067-019-04480.
    PubMed     Text format     Abstract available
    
    
    
66. ZHOU H, Hu B, Zhaopeng Z, Liu J, et al
    Elevated circulating T cell subsets and cytokines expression in patients with rheumatoid arthritis.
    Clin Rheumatol. 2019 Feb 26. pii: 10.1007/s10067-019-04465.
    PubMed     Text format     Abstract available
    
    
    
67. SALAFFI F, Di Carlo M, Farah S, Di Donato E, et al
    Prevalence of frailty and its associated factors in patients with rheumatoid arthritis: a cross-sectional analysis.
    Clin Rheumatol. 2019 Feb 26. pii: 10.1007/s10067-019-04486.
    PubMed     Text format     Abstract available
    
    
    
68. ALTEN R, Mariette X, Lorenz HM, Nusslein H, et al
    Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study.
    Clin Rheumatol. 2019 Feb 21. pii: 10.1007/s10067-019-04449.
    PubMed     Text format     Abstract available
    
    
    
69. SHIMADA H, Kameda T, Kanenishi K, Miyatake N, et al
    Effect of biologic disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis who hope to become mothers.
    Clin Rheumatol. 2019 Feb 7. pii: 10.1007/s10067-019-04450.
    PubMed     Text format     Abstract available
    
    
    
70. XIN F, Fu L, Liu H, Xu Y, et al
    Exploring metabolic and inflammatory abnormalities in rheumatoid arthritis patients developing stroke disease: a case-control study using electronic medical record data in northern China.
    Clin Rheumatol. 2019 Feb 7. pii: 10.1007/s10067-019-04440.
    PubMed     Text format     Abstract available
    
    
    
71. LIU C, Pan A, Chen X, Tu J, et al
    MiR-5571-3p and miR-135b-5p, derived from analyses of microRNA profile sequencing, correlate with increased disease risk and activity of rheumatoid arthritis.
    Clin Rheumatol. 2019 Feb 1. pii: 10.1007/s10067-018-04417.
    PubMed     Text format     Abstract available
    
    
    
72. YONG WC, Sanguankeo A, Upala S
    Association between primary Sjogren's syndrome, arterial stiffness, and subclinical atherosclerosis: a systematic review and meta-analysis.
    Clin Rheumatol. 2019;38:447-455.
    PubMed     Text format     Abstract available
    
    
    
73. CHERNOFF D, Scott Eastman P, Hwang CC, Flake DD 2nd, et al
    Determination of the minimally important difference (MID) in multi-biomarker disease activity (MBDA) test scores: impact of diurnal and daily biomarker variation patterns on MBDA scores.
    Clin Rheumatol. 2019;38:437-445.
    PubMed     Text format     Abstract available
    
    
    
74. HUI M, Zhao J, Tian Z, Wang J, et al
    Red blood cell distribution width as a potential predictor of survival of pulmonary arterial hypertension associated with primary Sjogren's syndrome: a retrospective cohort study.
    Clin Rheumatol. 2019;38:477-485.
    PubMed     Text format     Abstract available
    
    
    January 2019
75. LU MC, Livneh H, Chiu LM, Lai NS, et al
    A survey of traditional Chinese medicine use among rheumatoid arthritis patients: a claims data-based cohort study.
    Clin Rheumatol. 2019 Jan 22. pii: 10.1007/s10067-018-04425.
    PubMed     Text format     Abstract available
    
    
    
76. ELSHAFIE AI, Elbagir S, Aledrissy MIE, Elagib EM, et al
    Occurrence of anti-CCP2 and RF isotypes and their relation to age and disease severity among Sudanese patients with rheumatoid arthritis.
    Clin Rheumatol. 2019 Jan 17. pii: 10.1007/s10067-019-04431.
    PubMed     Text format     Abstract available
    
    
    
77. LEVERENZ DL, Eudy AM, Jayasundara M, Haroun T, et al
    Contraception methods used by women with rheumatoid arthritis and psoriatic arthritis.
    Clin Rheumatol. 2019 Jan 16. pii: 10.1007/s10067-018-04420.
    PubMed     Text format     Abstract available
    
    
    
78. GOSSELIN BOUCHER V, Colmegna I, Gemme C, Labbe S, et al
    Interventions to improve vaccine acceptance among rheumatoid arthritis patients: a systematic review.
    Clin Rheumatol. 2019 Jan 15. pii: 10.1007/s10067-019-04430.
    PubMed     Text format     Abstract available
    
    
    
79. VENERITO V, Lopalco G, Cacciapaglia F, Fornaro M, et al
    A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis.
    Clin Rheumatol. 2019 Jan 10. pii: 10.1007/s10067-018-04406.
    PubMed     Text format     Abstract available
    
    
    
80. DESHAPRIYA K
    Introduction of a uniform record keeping practice for rheumatology clinics in Sri Lanka-an ILAR project.
    Clin Rheumatol. 2019;38:159-164.
    PubMed     Text format     Abstract available
    
    
    
81. RAMOS GP, Skare T, Junior OR, Rabito E, et al
    Nutritional profile of patients with chronic inflammatory diseases in the age of biologicals.
    Clin Rheumatol. 2019;38:45-51.
    PubMed     Text format     Abstract available
    
    
    
82. SANDHU A, Ahmad S, Kaur P, Bhatnagar A, et al
    Methotrexate preferentially affects Tc1 and Tc17 subset of CD8 T lymphocytes.
    Clin Rheumatol. 2019;38:37-44.
    PubMed     Text format     Abstract available
    
    
    December 2018
83. MUCIENTES A, Fernandez-Gutierrez B, Herranz E, Rodriguez-Rodriguez L, et al
    Functional implications of single nucleotide polymorphisms rs662 and rs854860 on the antioxidative activity of paraoxonase1 (PON1) in patients with rheumatoid arthritis.
    Clin Rheumatol. 2018 Dec 26. pii: 10.1007/s10067-018-4394.
    PubMed     Text format     Abstract available
    
    
    
84. TARGONSKA-STEPNIAK B, Biskup M, Biskup W, Majdan M, et al
    Diastolic dysfunction in rheumatoid arthritis patients with low disease activity.
    Clin Rheumatol. 2018 Dec 12. pii: 10.1007/s10067-018-4369.
    PubMed     Text format     Abstract available
    
    
    
85. FU Q, Wang L, Li L, Li Y, et al
    Risk factors for progression and prognosis of rheumatoid arthritis-associated interstitial lung disease: single center study with a large sample of Chinese population.
    Clin Rheumatol. 2018 Dec 7. pii: 10.1007/s10067-018-4382.
    PubMed     Text format     Abstract available
    
    
    
86. SINGH A, Patro PS, Aggarwal A
    MicroRNA-132, miR-146a, and miR-155 as potential biomarkers of methotrexate response in patients with rheumatoid arthritis.
    Clin Rheumatol. 2018 Dec 3. pii: 10.1007/s10067-018-4380.
    PubMed     Text format     Abstract available
    
    
    
87. ALEX AM, Sayles H, Mikuls TR, Kerr GS, et al
    Evaluation of cytokine profiles in rheumatoid arthritis patients with clinically active disease and normal inflammatory indices.
    Clin Rheumatol. 2018 Dec 1. pii: 10.1007/s10067-018-4379.
    PubMed     Text format     Abstract available
    
    
    
88. HASSINE HB, Zemni R, Nacef IB, Boumiza A, et al
    A TRAF6 genetic variant is associated with low bone mineral density in rheumatoid arthritis.
    Clin Rheumatol. 2018 Dec 1. pii: 10.1007/s10067-018-4362.
    PubMed     Text format     Abstract available
    
    
    November 2018
89. BAZZICHI L, Nacci F, Sinigaglia L, Bianchino L, et al
    Subcutaneous tocilizumab alone or with a csDMARD in rheumatoid arthritis patients: subanalysis of Italian data from a multicenter phase IIIb/IV trial.
    Clin Rheumatol. 2018 Nov 12. pii: 10.1007/s10067-018-4327.
    PubMed     Text format     Abstract available
    
    
    
90. CORRALES O, Hernandez L, Prada D, Gomez J, et al
    CIGB-814, an altered peptide ligand derived from human heat-shock protein 60, decreases anti-cyclic citrullinated peptides antibodies in patients with rheumatoid arthritis.
    Clin Rheumatol. 2018 Nov 10. pii: 10.1007/s10067-018-4360.
    PubMed     Text format     Abstract available
    
    
    
91. SETO R, Mathias LM, Kelly A, Panush RS, et al
    Should a patient with rheumatoid arthritis be a kidney donor?
    Clin Rheumatol. 2018 Nov 8. pii: 10.1007/s10067-018-4350.
    PubMed     Text format     Abstract available
    
    
    
92. MARTINEZ-FEITO A, Plasencia-Rodriguez C, Navarro-Compan V, Hernandez-Breijo B, et al
    The effect of methotrexate versus other disease-modifying anti-rheumatic drugs on serum drug levels and clinical response in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors.
    Clin Rheumatol. 2018 Nov 6. pii: 10.1007/s10067-018-4355.
    PubMed     Text format     Abstract available
    
    
    
93. DONG X, Zhou J, Guo X, Li Y, et al
    A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjogren's syndrome-related interstitial lung disease in a Chinese population.
    Clin Rheumatol. 2018;37:2981-2988.
    PubMed     Text format     Abstract available
    
    
    
94. LI Z, Fu T, Li L, Cui Y, et al
    Prevalence, severity, and predictors of dry eye and dry mouth in Chinese patients with primary Sjogren syndrome.
    Clin Rheumatol. 2018;37:2971-2979.
    PubMed     Text format     Abstract available
    
    
    
95. LIU Z, Wang J, Lai J, Wang Q, et al
    Is it possible to apply the treat-to-target strategy in primary Sjogren's syndrome-associated pulmonary arterial hypertension?
    Clin Rheumatol. 2018;37:2989-2998.
    PubMed     Text format     Abstract available
    
    
    October 2018
96. YU C, Jin S, Wang Y, Jiang N, et al
    Remission rate and predictors of remission in patients with rheumatoid arthritis under treat-to-target strategy in real-world studies: a systematic review and meta-analysis.
    Clin Rheumatol. 2018 Oct 19. pii: 10.1007/s10067-018-4340.
    PubMed     Text format     Abstract available
    
    
    
97. ABASOLO L, Ivorra-Cortes J, Leon L, Jover JA, et al
    Contribution of the bone and cartilage/soft tissue components of the joint damage to the level of disability in rheumatoid arthritis patients: a longitudinal study.
    Clin Rheumatol. 2018 Oct 16. pii: 10.1007/s10067-018-4335.
    PubMed     Text format     Abstract available
    
    
    
98. GAMAL RM, Hammam N, Zakary MM, Abdelaziz MM, et al
    Telomere dysfunction-related serological markers and oxidative stress markers in rheumatoid arthritis patients: correlation with diseases activity.
    Clin Rheumatol. 2018 Oct 16. pii: 10.1007/s10067-018-4318.
    PubMed     Text format     Abstract available
    
    
    
99. LIU Q, Yang J, He H, Yu Y, et al
    Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis and meta-regression.
    Clin Rheumatol. 2018 Oct 16. pii: 10.1007/s10067-018-4329.
    PubMed     Text format     Abstract available
    
    
    
100. LEE SY, Kong IG, Oh DJ, Choi HG, et al
     Increased risk of sudden sensory neural hearing loss in patients with rheumatoid arthritis: a longitudinal follow-up study using a national sample cohort.
     Clin Rheumatol. 2018 Oct 15. pii: 10.1007/s10067-018-4333.
     PubMed     Text format     Abstract available
     
     
     
101. ROTAR Z, Tomsic M, Praprotnik S
     The persistence of golimumab compared to other tumour necrosis factor-alpha inhibitors in daily clinical practice for the treatment of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: observations from the Slovenian nation-wide lo
     Clin Rheumatol. 2018 Oct 15. pii: 10.1007/s10067-018-4324.
     PubMed     Text format     Abstract available
     
     
     
102. RUARO B, Casabella A, Paolino S, Pizzorni C, et al
     Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS).
     Clin Rheumatol. 2018 Oct 6. pii: 10.1007/s10067-018-4322.
     PubMed     Text format     Abstract available
     
     
     
103. ENGLAND BR, Sayles H, Michaud K, Thiele GM, et al
     Chronic lung disease in U.S. Veterans with rheumatoid arthritis and the impact on survival.
     Clin Rheumatol. 2018 Oct 2. pii: 10.1007/s10067-018-4314.
     PubMed     Text format     Abstract available
     
     
     
104. LUCHETTI MM, Benfaremo D, Campanati A, Molinelli E, et al
     Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic.
     Clin Rheumatol. 2018;37:2741-2749.
     PubMed     Text format     Abstract available
     
     
     September 2018
105. RENSKERS L, van Uden RJJC, Huis AMP, Rongen SAA, et al
     Comparison of the construct validity and reproducibility of four different types of patient-reported outcome measures (PROMs) in patients with rheumatoid arthritis.
     Clin Rheumatol. 2018 Sep 12. pii: 10.1007/s10067-018-4285.
     PubMed     Text format     Abstract available
     
     
     
106. KANG JH, Xirasagar S, Lin HC, Kao PF, et al
     Risk of adverse outcomes in patients with rheumatoid arthritis hospitalized for stroke-a cross-sectional study.
     Clin Rheumatol. 2018 Sep 12. pii: 10.1007/s10067-018-4287.
     PubMed     Text format     Abstract available
     
     
     
107. ARAYSSI T, Harfouche M, Darzi A, Al Emadi S, et al
     Correction to: Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines.
     Clin Rheumatol. 2018 Sep 6. pii: 10.1007/s10067-018-4282.
     PubMed     Text format     Abstract available
     
     
     
108. JULICH M, Kanne AM, Sehnert B, Budweiser S, et al
     Serological lymphocytic activity and patient-reported outcomes in Sjogren's syndrome.
     Clin Rheumatol. 2018;37:2361-2366.
     PubMed     Text format     Abstract available
     
     
     
109. JONES B, Hassan I, Tsuyuki RT, Dos Santos MF, et al
     Hot joints: myth or reality? A thermographic joint assessment of inflammatory arthritis patients.
     Clin Rheumatol. 2018;37:2567-2571.
     PubMed     Text format     Abstract available
     
     
     
110. SOARE A, Gheorghiu AM, Arama V, Bumbacea D, et al
     Risk of active tuberculosis in patients with inflammatory arthritis receiving TNF inhibitors: a look beyond the baseline tuberculosis screening protocol.
     Clin Rheumatol. 2018;37:2391-2397.
     PubMed     Text format     Abstract available
     
     
     
111. TRAN HW, Panush RS
     Some days you win.
     Clin Rheumatol. 2018;37:2585-2586.
     PubMed     Text format    
     
     
     August 2018
112. BAE SC, Lee YH
     Coffee consumption and the risk of rheumatoid arthritis and systemic lupus erythematosus: a Mendelian randomization study.
     Clin Rheumatol. 2018 Aug 30. pii: 10.1007/s10067-018-4278.
     PubMed     Text format     Abstract available
     
     
     
113. GOSSEC L, Berenbaum F, Chauvin P, Hudry C, et al
     Correction to: Development and application of a questionnaire to assess patient beliefs in rheumatoid arthritis and axial spondyloarthritis.
     Clin Rheumatol. 2018 Aug 24. pii: 10.1007/s10067-018-4241.
     PubMed     Text format     Abstract available
     
     
     
114. YEGANEH F, Mousavi SMJ, Hosseinzadeh-Sarband S, Ahmadzadeh A, et al
     Association of CD26/dipeptidyl peptidase IV mRNA level in peripheral blood mononuclear cells with disease activity and bone erosion in rheumatoid arthritis.
     Clin Rheumatol. 2018 Aug 22. pii: 10.1007/s10067-018-4268.
     PubMed     Text format     Abstract available
     
     
     
115. SPARKS JA, Barbhaiya M, Tedeschi SK, Leatherwood CL, et al
     Inflammatory dietary pattern and risk of developing rheumatoid arthritis in women.
     Clin Rheumatol. 2018 Aug 14. pii: 10.1007/s10067-018-4261.
     PubMed     Text format     Abstract available
     
     
     
116. ARAYSSI T, Harfouche M, Darzi A, Al Emadi S, et al
     Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines.
     Clin Rheumatol. 2018 Aug 10. pii: 10.1007/s10067-018-4245.
     PubMed     Text format     Abstract available
     
     
     
117. VAN DER HEIJDE D, Durez P, Schett G, Naredo E, et al
     Structural damage progression in patients with early rheumatoid arthritis treated with methotrexate, baricitinib, or baricitinib plus methotrexate based on clinical response in the phase 3 RA-BEGIN study.
     Clin Rheumatol. 2018 Aug 4. pii: 10.1007/s10067-018-4221.
     PubMed     Text format     Abstract available
     
     
     
118. JESE R, Perdan-Pirkmajer K, Hocevar A, Rotar Z, et al
     The incidence rate and the early management of rheumatoid arthritis in Slovenia.
     Clin Rheumatol. 2018 Aug 2. pii: 10.1007/s10067-018-4235.
     PubMed     Text format     Abstract available
     
     
     
119. KAWAZOE M, Kaneko K, Shikano K, Kusunoki N, et al
     Glucocorticoid therapy causes contradictory changes of serum Wnt signaling-related molecules in systemic autoimmune diseases.
     Clin Rheumatol. 2018;37:2169-2178.
     PubMed     Text format     Abstract available
     
     
     July 2018
120. COLAK S, Sandikci SC, Gokmen D, Omma A, et al
     The relationship between bristol rheumatoid arthritis fatigue scales and disease activity of patients with rheumatoid arthritis.
     Clin Rheumatol. 2018 Jul 30. pii: 10.1007/s10067-018-4224.
     PubMed     Text format     Abstract available
     
     
     
121. CANSU DU, Teke HU, Bodakci E, Korkmaz C, et al
     How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis?
     Clin Rheumatol. 2018 Jul 28. pii: 10.1007/s10067-018-4242.
     PubMed     Text format     Abstract available
     
     
     
122. PHUAN-UDOM R, Lektrakul N, Katchamart W
     The association between 10-year fracture risk by FRAX and osteoporotic fractures with disease activity in patients with rheumatoid arthritis.
     Clin Rheumatol. 2018 Jul 23. pii: 10.1007/s10067-018-4218.
     PubMed     Text format     Abstract available
     
     
     
123. ISMAIL M, Khawaja G
     Study of cannabinoid receptor 2 Q63R gene polymorphism in Lebanese patients with rheumatoid arthritis.
     Clin Rheumatol. 2018 Jul 21. pii: 10.1007/s10067-018-4217.
     PubMed     Text format     Abstract available
     
     
     
124. OTSUBO H, Tsuneyoshi Y, Nakamura T, Matsuda T, et al
     Serum-soluble folate receptor beta as a biomarker for the activity of rheumatoid arthritis synovitis and the response to anti-TNF agents.
     Clin Rheumatol. 2018 Jul 18. pii: 10.1007/s10067-018-4202.
     PubMed     Text format     Abstract available
     
     
     
125. DE ANDRADE AP, Inoue EN, Nisihara R, Skare TL, et al
     Foot function in rheumatoid arthritis patients: a cross-sectional study.
     Clin Rheumatol. 2018 Jul 14. pii: 10.1007/s10067-018-4215.
     PubMed     Text format     Abstract available
     
     
     
126. KUNWAR S, Collins CE, Constantinescu F
     Baricitinib, a Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials.
     Clin Rheumatol. 2018 Jul 13. pii: 10.1007/s10067-018-4199.
     PubMed     Text format     Abstract available
     
     
     
127. WAH-SUAREZ MI, Galarza-Delgado DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, et al
     The best cardiovascular risk calculator to predict carotid plaques in rheumatoid arthritis patients.
     Clin Rheumatol. 2018 Jul 2. pii: 10.1007/s10067-018-4181.
     PubMed     Text format     Abstract available
     
     
     
128. CHEN X, Wu H, Wei W
     Advances in the diagnosis and treatment of Sjogren's syndrome.
     Clin Rheumatol. 2018;37:1743-1749.
     PubMed     Text format     Abstract available
     
     
     
129. WANG Y, Zhao S, Du G, Ma S, et al
     Acute fibrinous and organizing pneumonia as initial presentation of primary Sjogren's syndrome: a case report and literature review.
     Clin Rheumatol. 2018;37:2001-2005.
     PubMed     Text format     Abstract available
     
     
     June 2018
130. XUE L, Li X, Chen Q, He J, et al
     Associations between D3R expression in synovial mast cells and disease activity and oxidant status in patients with rheumatoid arthritis.
     Clin Rheumatol. 2018 Jun 22. pii: 10.1007/s10067-018-4168.
     PubMed     Text format     Abstract available
     
     
     
131. GOSSEC L, Berenbaum F, Chauvin P, Hudry C, et al
     Development and application of a questionnaire to assess patient beliefs in rheumatoid arthritis and axial spondyloarthritis.
     Clin Rheumatol. 2018 Jun 12. pii: 10.1007/s10067-018-4172.
     PubMed     Text format     Abstract available
     
     
     
132. VAN ONNA M, Ozturk B, Starmans M, Peeters R, et al
     Disease and management beliefs of elderly patients with rheumatoid arthritis and comorbidity: a qualitative study.
     Clin Rheumatol. 2018 Jun 9. pii: 10.1007/s10067-018-4167.
     PubMed     Text format     Abstract available
     
     
     
133. AL-GAREEB AIA, Gorial FI, Mahmood AS
     Niclosamide as an adjuvant to etanercept in treatment patients with active rheumatoid arthritis: an 8-week randomized controlled pilot study.
     Clin Rheumatol. 2018 Jun 7. pii: 10.1007/s10067-018-4164.
     PubMed     Text format     Abstract available
     
     
     
134. SHIMADA K, Yokosuka K, Nunokawa T, Sugii S, et al
     Differences in clinical Pneumocystis pneumonia in rheumatoid arthritis and other connective tissue diseases suggesting a rheumatoid-specific interstitial lung injury spectrum.
     Clin Rheumatol. 2018 Jun 6. pii: 10.1007/s10067-018-4157.
     PubMed     Text format     Abstract available
     
     
     
135. KAVANAUGH A, Singh R, Karki C, Etzel CJ, et al
     Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis.
     Clin Rheumatol. 2018 Jun 4. pii: 10.1007/s10067-018-4140.
     PubMed     Text format     Abstract available
     
     
     May 2018
136. ZHU T, Zhao WL, Zeng YP, Liu YH, et al
     Systemic sclerosis-rheumatoid arthritis overlap syndrome complicated with Sweet's syndrome.
     Clin Rheumatol. 2018 May 25. pii: 10.1007/s10067-018-4150.
     PubMed     Text format     Abstract available
     
     
     
137. BAE SC, Lee YH
     Vitamin D level and risk of systemic lupus erythematosus and rheumatoid arthritis: a Mendelian randomization.
     Clin Rheumatol. 2018 May 24. pii: 10.1007/s10067-018-4152.
     PubMed     Text format     Abstract available
     
     
     
138. RAMBOD M, Nazarinia M, Raieskarimian F
     The impact of dietary habits on the pathogenesis of rheumatoid arthritis: a case-control study.
     Clin Rheumatol. 2018 May 22. pii: 10.1007/s10067-018-4151.
     PubMed     Text format     Abstract available
     
     
     
139. TURK SM, Cansu DU, Teke HU, Kasifoglu T, et al
     Can we predict thrombotic tendency in rheumatoid arthritis? A thromboelastographic analysis (with ROTEM).
     Clin Rheumatol. 2018 May 7. pii: 10.1007/s10067-018-4134.
     PubMed     Text format     Abstract available
     
     
     
140. DUREZ P, Pavelka K, Lazaro MA, Garcia-Kutzbach A, et al
     Regional differences in baseline disease activity and remission rates following golimumab treatment for RA: results from the GO-MORE trial.
     Clin Rheumatol. 2018;37:1417-1420.
     PubMed     Text format     Abstract available
     
     
     
141. KOSLOW M, Kivity S, Vishnevskia-Dai V, Ben-Dov I, et al
     Unexplained cough: it is time to rule out Sjogren's syndrome.
     Clin Rheumatol. 2018;37:1215-1222.
     PubMed     Text format     Abstract available
     
     
     
142. YANG H, Sun Y, Zhao L, Zhang X, et al
     Cerebellar involvement in patients withprimary Sjogren's syndrome: diagnosis and treatment.
     Clin Rheumatol. 2018;37:1207-1213.
     PubMed     Text format     Abstract available
     
     
     
143. HE D, Liu J, Hai Y, Zhu Q, et al
     Increased DOT1L in synovial biopsies of patients with OA and RA.
     Clin Rheumatol. 2018;37:1327-1332.
     PubMed     Text format     Abstract available
     
     
     
144. XU X, Zhu T, Wu D, Zhang L, et al
     Sjogren's syndrome initially presented as thrombotic thrombocytopenic purpura in a male patient: a case report and literature review.
     Clin Rheumatol. 2018;37:1421-1426.
     PubMed     Text format     Abstract available
     
     
     April 2018
145. PAPPAS DA, Nyberg F, Kremer JM, Lampl K, et al
     Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study.
     Clin Rheumatol. 2018 Apr 25. pii: 10.1007/s10067-018-4113.
     PubMed     Text format     Abstract available
     
     
     
146. QUINTANA R, Goni M, Mathern N, Jorfen M, et al
     Rheumatoid arthritis in the indigenous qom population of Rosario, Argentina: aggressive and disabling disease with inadequate adherence to treatment in a community-based cohort study.
     Clin Rheumatol. 2018 Apr 19. pii: 10.1007/s10067-018-4103.
     PubMed     Text format     Abstract available
     
     
     
147. LUO Y, Fan X, Jiang C, Arevalo Molina AB, et al
     Rheumatoid arthritis is associated with increased in-hospital mortality in asthma exacerbations: a nationwide study.
     Clin Rheumatol. 2018 Apr 19. pii: 10.1007/s10067-018-4114.
     PubMed     Text format     Abstract available
     
     
     
148. TYMMS K, Littlejohn G, Griffiths H, de Jager J, et al
     Treatment patterns among patients with rheumatic disease (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated arthritis (UnA)) treated with subcutaneous TNF inhibitors.
     Clin Rheumatol. 2018 Apr 18. pii: 10.1007/s10067-018-4105.
     PubMed     Text format     Abstract available
     
     
     
149. GAO H, Ma XX, Guo Q, Xie LF, et al
     Expression of circulating Semaphorin3A and its association with inflammation and bone destruction in rheumatoid arthritis.
     Clin Rheumatol. 2018 Apr 14. pii: 10.1007/s10067-018-4070.
     PubMed     Text format     Abstract available
     
     
     
150. STRAND V, Lee EB, Yazici Y, Dikranian A, et al
     Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trials.
     Clin Rheumatol. 2018 Apr 14. pii: 10.1007/s10067-018-4077.
     PubMed     Text format     Abstract available
     
     
     
151. HURNAKOVA J, Hulejova H, Zavada J, Komarc M, et al
     Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein.
     Clin Rheumatol. 2018 Apr 14. pii: 10.1007/s10067-018-4091.
     PubMed     Text format     Abstract available
     
     
     
152. KOOHINI Z, Hossein-Nataj H, Mobini M, Hosseinian-Amiri A, et al
     Analysis of PD-1 and Tim-3 expression on CD4(+) T cells of patients with rheumatoid arthritis; negative association with DAS28.
     Clin Rheumatol. 2018 Apr 7. pii: 10.1007/s10067-018-4076.
     PubMed     Text format     Abstract available
     
     
     
153. KHOJAH HM, Ahmed S, Abdel-Rahman MS, Elhakeim EH, et al
     Resveratrol as an effective adjuvant therapy in the management of rheumatoid arthritis: a clinical study.
     Clin Rheumatol. 2018 Apr 3. pii: 10.1007/s10067-018-4080.
     PubMed     Text format     Abstract available
     
     
     
154. LILIANG PC, Liang CL, Lu K, Yang SN, et al
     Population-based study suggests an increased risk of Alzheimer'sdisease in Sjogren's syndrome.
     Clin Rheumatol. 2018;37:935-941.
     PubMed     Text format     Abstract available
     
     
     
155. OLMEZ MO, Gunal EK, Ureyen SB, Keskin H, et al
     Comparison of composite indices with global synovitis score on ultrasound for detecting remission.
     Clin Rheumatol. 2018;37:1111-1114.
     PubMed     Text format     Abstract available
     
     
     March 2018
156. SUDA M, Ohde S, Tsuda T, Kishimoto M, et al
     Safety and efficacy of alternate-day corticosteroid treatment as adjunctive therapy for rheumatoid arthritis: a comparative study.
     Clin Rheumatol. 2018 Mar 26. pii: 10.1007/s10067-018-4073.
     PubMed     Text format     Abstract available
     
     
     
157. ANNO S, Sugioka Y, Inui K, Tada M, et al
     Evaluation of work disability in Japanese patients with rheumatoid arthritis: from the TOMORROW study.
     Clin Rheumatol. 2018 Mar 10. pii: 10.1007/s10067-018-4060.
     PubMed     Text format     Abstract available
     
     
     
158. FERREIRA RJO, Eugenio G, Ndosi M, Silva C, et al
     Influence of the different "patient global assessment" formulations on disease activity score by different indices in rheumatoid arthritis.
     Clin Rheumatol. 2018 Mar 10. pii: 10.1007/s10067-018-4063.
     PubMed     Text format     Abstract available
     
     
     
159. YANG L, Zou QH, Zhang Y, Shi Y, et al
     Proteomic analysis of plasma from rheumatoid arthritis patients with mild cognitive impairment.
     Clin Rheumatol. 2018 Mar 10. pii: 10.1007/s10067-017-3974.
     PubMed     Text format     Abstract available
     
     
     
160. ENGELMANN R, Nekarda S, Kuthning D, Kneitz C, et al
     Decreased IgG4 ACPA levels in responders and increased CD1c(+) classical dendritic cells in non-responders of patients with rheumatoid arthritis under therapy.
     Clin Rheumatol. 2018 Mar 3. pii: 10.1007/s10067-018-4053.
     PubMed     Text format     Abstract available
     
     
     
161. DES BORDES JKA, Gonzalez E, Lopez-Olivo MA, Shethia M, et al
     Assessing information needs and use of online resources for disease self-management in patients with rheumatoid arthritis: a qualitative study.
     Clin Rheumatol. 2018 Mar 2. pii: 10.1007/s10067-018-4047.
     PubMed     Text format     Abstract available
     
     
     
162. ROTHSCHILD BM
     Differential diagnostic perspectives provided by en face microscopic examination of articular surface defects.
     Clin Rheumatol. 2018;37:831-836.
     PubMed     Text format     Abstract available
     
     
     
163. FIDELIX T, Czapkowski A, Azjen S, Andriolo A, et al
     Low-level laser therapy for xerostomia in primary Sjogren's syndrome: a randomized trial.
     Clin Rheumatol. 2018;37:729-736.
     PubMed     Text format     Abstract available
     
     
     
164. SANTILLAN-DIAZ C, Ramirez-Sanchez N, Espinosa-Morales R, Orea-Tejeda A, et al
     Prevalence of rheumatoid cachexia assessed by bioelectrical impedance vector analysis and its relation with physical function.
     Clin Rheumatol. 2018;37:607-614.
     PubMed     Text format     Abstract available
     
     
     February 2018
165. HUANG Z, Niu Q, Yang B, Zhang J, et al
     Genetic polymorphism of rs9277535 in HLA-DP associated with rheumatoid arthritis and anti-CCP production in a Chinese population.
     Clin Rheumatol. 2018 Feb 23. pii: 10.1007/s10067-018-4030.
     PubMed     Text format     Abstract available
     
     
     
166. GOSSEC L, Kirwan JR, de Wit M, Balanescu A, et al
     Phrasing of the patient global assessment in the rheumatoid arthritis ACR/EULAR remission criteria: an analysis of 967 patients from two databases of early and established rheumatoid arthritis patients.
     Clin Rheumatol. 2018 Feb 21. pii: 10.1007/s10067-018-3998.
     PubMed     Text format     Abstract available
     
     
     
167. PERROTTA FM, De Socio A, Scriffignano S, Lubrano E, et al
     Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study.
     Clin Rheumatol. 2018 Feb 21. pii: 10.1007/s10067-018-4038.
     PubMed     Text format     Abstract available
     
     
     
168. MEDINA YF, Ruiz-Gaviria RE, Buitrago-Lopez A, Villota C, et al
     Physical articular examination in the activity of rheumatoid arthritis: a systematic review of the literature : Systematic review of the literature regarding physical examination in rheumatoid arthritis.
     Clin Rheumatol. 2018 Feb 20. pii: 10.1007/s10067-018-4015.
     PubMed     Text format     Abstract available
     
     
     
169. LI J, Che N, Xu L, Zhang Q, et al
     LC-MS-based serum metabolomics reveals a distinctive signature in patients with rheumatoid arthritis.
     Clin Rheumatol. 2018 Feb 13. pii: 10.1007/s10067-018-4021.
     PubMed     Text format     Abstract available
     
     
     
170. SARI F, Oskay D, Tufan A
     Reliability, validity, and cross-cultural adaptation of the Turkish version of the Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire.
     Clin Rheumatol. 2018 Feb 8. pii: 10.1007/s10067-018-4008.
     PubMed     Text format     Abstract available
     
     
     
171. GUNTER S, Robinson C, Norton GR, Woodiwiss AJ, et al
     Disease severity impacts the relationship of apelin with arterial function in patients with rheumatoid arthritis.
     Clin Rheumatol. 2018 Feb 8. pii: 10.1007/s10067-018-4013.
     PubMed     Text format     Abstract available
     
     
     
172. BAE SC, Lee YH
     Comparison of the efficacy and tolerability of tocilizumab, sarilumab, and sirukumab in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.
     Clin Rheumatol. 2018 Feb 5. pii: 10.1007/s10067-018-4006.
     PubMed     Text format     Abstract available
     
     
     
173. VERSTEEG GA, Steunebrink LMM, Vonkeman HE, Ten Klooster PM, et al
     Long-term disease and patient-reported outcomes of a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily clinical practice.
     Clin Rheumatol. 2018 Feb 1. pii: 10.1007/s10067-017-3962.
     PubMed     Text format     Abstract available
     
     
     
174. BAE SC, Lee YH
     Comparative efficacy and safety of biosimilar adalimumab and originator adalimumab in combination with methotrexate in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.
     Clin Rheumatol. 2018 Feb 1. pii: 10.1007/s10067-018-4002.
     PubMed     Text format     Abstract available
     
     
     
175. SHOVMAN O, Tamar S, Amital H, Watad A, et al
     Diverse patterns of anti-TNF-alpha-induced lupus: case series and review of the literature.
     Clin Rheumatol. 2018;37:563-568.
     PubMed     Text format     Abstract available
     
     
     
176. VLACHOPOULOS C, Gravos A, Georgiopoulos G, Terentes-Printzios D, et al
     The effect of TNF-a antagonists on aortic stiffness and wave reflections: a meta-analysis.
     Clin Rheumatol. 2018;37:515-526.
     PubMed     Text format     Abstract available
     
     
     
177. TANG MW, van Nierop FS, Koopman FA, Eggink HM, et al
     Single vagus nerve stimulation reduces early postprandial C-peptide levels but not other hormones or postprandial metabolism.
     Clin Rheumatol. 2018;37:505-514.
     PubMed     Text format     Abstract available
     
     
     January 2018
178. KARDOS Z, Olah C, Sepsi M, Sas A, et al
     Increased frequency of temporal acoustic window failure in rheumatoid arthritis: a manifestation of altered bone metabolism?
     Clin Rheumatol. 2018 Jan 30. pii: 10.1007/s10067-018-4003.
     PubMed     Text format     Abstract available
     
     
     
179. CONN DL, Tiliakos A, Bao G, Liu S, et al
     Correction to: Effect of daily low dose prednisone, divided or single daily dose, in the treatment of African Americans with early rheumatoid arthritis.
     Clin Rheumatol. 2018 Jan 29. pii: 10.1007/s10067-018-3996.
     PubMed     Text format     Abstract available
     
     
     
180. PETERSEN LE, Baptista TSA, Molina JK, Motta JG, et al
     Cognitive impairment in rheumatoid arthritis: role of lymphocyte subsets, cytokines and neurotrophic factors.
     Clin Rheumatol. 2018 Jan 25. pii: 10.1007/s10067-018-3990.
     PubMed     Text format     Abstract available
     
     
     
181. ROMANO C, Del Mastro A, Sellitto A, Solaro E, et al
     Tocilizumab reduces complement C3 and C4 serum levels in rheumatoid arthritis patients.
     Clin Rheumatol. 2018 Jan 23. pii: 10.1007/s10067-018-3992.
     PubMed     Text format     Abstract available
     
     
     
182. KIADALIRI AA, Englund M
     Temporal trends and regional disparity in rheumatoid arthritis and gout hospitalizations in Sweden, 1998-2015.
     Clin Rheumatol. 2018 Jan 22. pii: 10.1007/s10067-018-3983.
     PubMed     Text format     Abstract available
     
     
     
183. YU X, Zhang L, Wang L, Lu W, et al
     MRI assessment of erosion repair in patients with long-standing rheumatoid arthritis receiving double-filtration plasmapheresis in addition to leflunomide and methotrexate: a randomized controlled trial.
     Clin Rheumatol. 2018 Jan 8. pii: 10.1007/s10067-017-3956.
     PubMed     Text format     Abstract available
     
     
     
184. RONGEN GA, van Ingen I, Kok M, Vonkeman H, et al
     Vasodilator function worsens after cessation of tumour necrosis factor inhibitor therapy in patients with rheumatoid arthritis only if a flare occurs.
     Clin Rheumatol. 2018 Jan 7. pii: 10.1007/s10067-017-3961.
     PubMed     Text format     Abstract available
     
     
     
185. CHEN MH, Lee MH, Liao HT, Chen WS, et al
     Health-related quality of life outcomes in patients with rheumatoid arthritis and ankylosing spondylitis after tapering biologic treatment.
     Clin Rheumatol. 2018 Jan 6. pii: 10.1007/s10067-017-3965.
     PubMed     Text format     Abstract available
     
     
     
186. LU C, Xu K, Guo H, Peng K, et al
     The relationship of PADI4_94 polymorphisms with the morbidity of rheumatoid arthritis in Caucasian and Asian populations: a meta-analysis and system review.
     Clin Rheumatol. 2018 Jan 4. pii: 10.1007/s10067-017-3964.
     PubMed     Text format     Abstract available
     
     
     
187. CONN DL, Tiliakos A, Bao G, Li S, et al
     Effect of daily low dose prednisone, divided or single daily dose, in the treatment of African Americans with early rheumatoid arthritis.
     Clin Rheumatol. 2018 Jan 3. pii: 10.1007/s10067-017-3943.
     PubMed     Text format     Abstract available
     
     
     
188. GENG Y, Zhao Y, Zhang Z
     Tubulointerstitial nephritis-induced hypophosphatemic osteomalacia in Sjogren's syndrome: a case report and review of the literature.
     Clin Rheumatol. 2018;37:257-263.
     PubMed     Text format     Abstract available
     
     
     December 2017
189. SANTOS AM, Saldarriaga EL, Giraldo-Bustos R, Ballesteros-Munoz JG, et al
     Dickkopf 1 protein circulating levels as a possible biomarker of functional disability and chronic damage in patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 Dec 27. pii: 10.1007/s10067-017-3957.
     PubMed     Text format     Abstract available
     
     
     
190. KUUSALO L, Puolakka K, Kautiainen H, Karjalainen A, et al
     High burden of adverse events is associated with reduced remission rates in early rheumatoid arthritis.
     Clin Rheumatol. 2017 Dec 26. pii: 10.1007/s10067-017-3958.
     PubMed     Text format     Abstract available
     
     
     
191. GALARZA-DELGADO DA, Villegas Gonzalez MJ, Riega Torres J, Soto-Galindo GA, et al
     Early hearing loss detection in rheumatoid arthritis and primary Sjogren syndrome using extended high frequency audiometry.
     Clin Rheumatol. 2017 Dec 22. pii: 10.1007/s10067-017-3959.
     PubMed     Text format     Abstract available
     
     
     
192. RAMIREZ-FLORENCIO M, Jimenez-Morales S, Barbosa-Cobos RE, Lopez-Cano DJ, et al
     High frequency of mutant thiopurine S-methyltransferase genotypes in Mexican patients with systemic lupus erythematosus and rheumatoid arthritis.
     Clin Rheumatol. 2017 Dec 20. pii: 10.1007/s10067-017-3955.
     PubMed     Text format     Abstract available
     
     
     
193. BARBOSA-COBOS RE, Lugo-Zamudio G, Flores-Estrada J, Becerril-Mendoza LT, et al
     Serum substance P: an indicator of disease activity and subclinical inflammation in rheumatoid arthritis.
     Clin Rheumatol. 2017 Dec 18. pii: 10.1007/s10067-017-3929.
     PubMed     Text format     Abstract available
     
     
     
194. CARRANZA-LEON D, Octaria R, Ormseth MJ, Oeser A, et al
     Association between urinary sodium and potassium excretion and blood pressure and inflammation in patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 Dec 14. pii: 10.1007/s10067-017-3935.
     PubMed     Text format     Abstract available
     
     
     
195. CURTIS JR, Trivedi M, Haraoui B, Emery P, et al
     Defining and characterizing sustained remission in patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 Dec 9. pii: 10.1007/s10067-017-3923.
     PubMed     Text format     Abstract available
     
     
     
196. EUDY AM, McDaniel G, Clowse MEB
     Pregnancy in rheumatoid arthritis: a retrospective study.
     Clin Rheumatol. 2017 Dec 8. pii: 10.1007/s10067-017-3939.
     PubMed     Text format    
     
     
     November 2017
197. WANG L, Tan W, Wang F, Shen Y, et al
     Artery compliance in patients with rheumatoid arthritis: results from a case-control study.
     Clin Rheumatol. 2017 Nov 13. doi: 10.1007/s10067-017-3899.
     PubMed     Text format     Abstract available
     
     
     
198. HASSINE HB, Sghiri R, Chabchoub E, Boumiza A, et al
     IRAK2 is associated with susceptibility to rheumatoid arthritis.
     Clin Rheumatol. 2017 Nov 11. doi: 10.1007/s10067-017-3906.
     PubMed     Text format     Abstract available
     
     
     
199. CHARLES-SCHOEMAN C, Meriwether D, Lee YY, Shahbazian A, et al
     High levels of oxidized fatty acids in HDL are associated with impaired HDL function in patients with active rheumatoid arthritis.
     Clin Rheumatol. 2017 Nov 11. doi: 10.1007/s10067-017-3896.
     PubMed     Text format     Abstract available
     
     
     
200. ZHU H, Li R, Da Z, Bi L, et al
     Remission assessment of rheumatoid arthritis in daily practice in China: a cross-sectional observational study.
     Clin Rheumatol. 2017 Nov 7. doi: 10.1007/s10067-017-3850.
     PubMed     Text format     Abstract available
     
     
     
201. HE Y, Liu C, Zeng Z, Ye W, et al
     Red blood cell distribution width: a potential laboratory parameter for monitoring inflammation in rheumatoid arthritis.
     Clin Rheumatol. 2017 Nov 3. doi: 10.1007/s10067-017-3871.
     PubMed     Text format     Abstract available
     
     
     
202. BATUN-GARRIDO JAJ, Salas-Magana M, Juarez-Rojop IE
     Association between leptin and IL-6 concentrations with cardiovascular risk in patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 Nov 3. doi: 10.1007/s10067-017-3897.
     PubMed     Text format     Abstract available
     
     
     
203. MASSONE F, Martinez ME, Pascual-Ramos V, Quintana R, et al
     Educational website incorporating rheumatoid arthritis patient needs for Latin American and Caribbean countries.
     Clin Rheumatol. 2017 Nov 2. doi: 10.1007/s10067-017-3866.
     PubMed     Text format     Abstract available
     
     
     
204. BISI MC, do Prado AD, Piovesan DM, Bredemeier M, et al
     Correction to: Ultrasound resistive index, power Doppler, and clinical parameters in established rheumatoid arthritis.
     Clin Rheumatol. 2017 Nov 2. doi: 10.1007/s10067-017-3882.
     PubMed     Text format     Abstract available
     
     
     October 2017
205. PU D, Luo J, Wang Y, Ju B, et al
     Prevalence of depression and anxiety in rheumatoid arthritis patients and their associations with serum vitamin D level.
     Clin Rheumatol. 2017 Oct 23. doi: 10.1007/s10067-017-3874.
     PubMed     Text format     Abstract available
     
     
     
206. NADA DW, El Morsy S, Abu-Zaid MH, Aboelhawa MA, et al
     The role of microalbuminuria as a predictor of subclinical cardiovascular events in rheumatoid arthritis patients and its relation to disease activity.
     Clin Rheumatol. 2017 Oct 23. doi: 10.1007/s10067-017-3849.
     PubMed     Text format     Abstract available
     
     
     
207. FU Q, Bai Y, Liu Y, Zhou J, et al
     The serum level and significance of lysyl oxidase-like 2 in patients with rheumatoid arthritis-associated interstitial lung disease.
     Clin Rheumatol. 2017 Oct 19. doi: 10.1007/s10067-017-3878.
     PubMed     Text format     Abstract available
     
     
     
208. OLARU L, Soong L, Dhillon S, Yacyshyn E, et al
     Coexistent rheumatoid arthritis and gout: a case series and review of the literature.
     Clin Rheumatol. 2017 Oct 12. doi: 10.1007/s10067-017-3856.
     PubMed     Text format     Abstract available
     
     
     
209. XING R, Sun L, Wu D, Jin Y, et al
     Autoantibodies against interleukin-21 correlate with disease activity in patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 Oct 10. doi: 10.1007/s10067-017-3862.
     PubMed     Text format     Abstract available
     
     
     
210. JAFRI K, Ogdie A, Qasim A, Patterson SL, et al
     Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis.
     Clin Rheumatol. 2017 Oct 9. doi: 10.1007/s10067-017-3860.
     PubMed     Text format     Abstract available
     
     
     
211. GO DJ, Shin K, Baek HJ, Kang SW, et al
     Pivotal factors for successful withdrawal of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis patients in remission or with low-disease activity.
     Clin Rheumatol. 2017 Oct 8. doi: 10.1007/s10067-017-3863.
     PubMed     Text format     Abstract available
     
     
     
212. IANNONE F, Ferraccioli G, Sinigaglia L, Favalli EG, et al
     Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics' register GISEA.
     Clin Rheumatol. 2017 Oct 5. doi: 10.1007/s10067-017-3846.
     PubMed     Text format     Abstract available
     
     
     
213. BAE SC, Lee YH
     Comparative efficacy and tolerability of monotherapy with leflunomide or tacrolimus for the treatment of rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.
     Clin Rheumatol. 2017 Oct 1. doi: 10.1007/s10067-017-3857.
     PubMed     Text format     Abstract available
     
     
     September 2017
214. MORTADA MA, Abdelwhab SM, Elgawish MH
     Intra-articular methotrexate versus corticosteroid injections in medium-sized joints of rheumatoid arthritis patients-an intervention study.
     Clin Rheumatol. 2017 Sep 30. doi: 10.1007/s10067-017-3843.
     PubMed     Text format     Abstract available
     
     
     
215. ROMAN-FERNANDEZ IV, Sanchez-Zuno GA, Padilla-Gutierrez JR, Cerpa-Cruz S, et al
     The 3'-UTR (CA)n microsatellite on CD40LG gene as a possible genetic marker for rheumatoid arthritis in Mexican population: impact on CD40LG mRNA expression.
     Clin Rheumatol. 2017 Sep 30. doi: 10.1007/s10067-017-3853.
     PubMed     Text format     Abstract available
     
     
     
216. LV M, Miao J, Zhao P, Luo X, et al
     CD147-mediated chemotaxis of CD4+CD161+ T cells may contribute to local inflammation in rheumatoid arthritis.
     Clin Rheumatol. 2017 Sep 25. doi: 10.1007/s10067-017-3800.
     PubMed     Text format     Abstract available
     
     
     
217. LIU XZ, Gao Y, Fan J, Xu X, et al
     Metabolic abnormalities in rheumatoid arthritis patients with comorbid diabetes mellitus.
     Clin Rheumatol. 2017 Sep 24. doi: 10.1007/s10067-017-3847.
     PubMed     Text format     Abstract available
     
     
     
218. HATTORI Y, Kida D, Kaneko A
     Normal serum matrix metalloproteinase-3 levels can be used to predict clinical remission and normal physical function in patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 Sep 22. doi: 10.1007/s10067-017-3829.
     PubMed     Text format     Abstract available
     
     
     
219. HANAOKA BY, Ormseth MJ, Michael Stein C, Banerjee D, et al
     Secretory sphingomyelinase (S-SMase) activity is elevated in patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 Sep 15. doi: 10.1007/s10067-017-3824.
     PubMed     Text format     Abstract available
     
     
     
220. MOHAMMED AT, Khattab M, Ahmed AM, Turk T, et al
     The therapeutic effect of probiotics on rheumatoid arthritis: a systematic review and meta-analysis of randomized control trials.
     Clin Rheumatol. 2017 Sep 15. doi: 10.1007/s10067-017-3814.
     PubMed     Text format     Abstract available
     
     
     
221. LU T, Zong M, Fan S, Lu Y, et al
     Thioredoxin 1 is associated with the proliferation and apoptosis of rheumatoid arthritis fibroblast-like synoviocytes.
     Clin Rheumatol. 2017 Sep 15. doi: 10.1007/s10067-017-3832.
     PubMed     Text format     Abstract available
     
     
     
222. HUANG AF, Su LC, Jia H, Liu Y, et al
     No association of single nucleotide polymorphisms within H19 and HOX transcript antisense RNA (HOTAIR) with genetic susceptibility to systemic lupus erythematosus, rheumatoid arthritis, and primary Sjogren's syndrome in a Chinese Han population.
     Clin Rheumatol. 2017 Sep 15. doi: 10.1007/s10067-017-3833.
     PubMed     Text format     Abstract available
     
     
     
223. PIERINGER H, Hintenberger R, Pohanka E, Steinwender C, et al
     RABBIT risk score and ICU admission due to infection in patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 Sep 14. doi: 10.1007/s10067-017-3825.
     PubMed     Text format     Abstract available
     
     
     
224. DU J, Chen S, Shi J, Zhu X, et al
     The association between the lymphocyte-monocyte ratio and disease activity in rheumatoid arthritis.
     Clin Rheumatol. 2017 Sep 14. doi: 10.1007/s10067-017-3815.
     PubMed     Text format     Abstract available
     
     
     
225. SAKTHISWARY R, Rajalingam S, Hussein H, Sridharan R, et al
     Cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and its correlation with sonographic knee cartilage thickness and disease activity.
     Clin Rheumatol. 2017 Sep 9. doi: 10.1007/s10067-017-3817.
     PubMed     Text format     Abstract available
     
     
     
226. REN J, Sun L, Zhao J
     Meta-analysis: diagnostic accuracy of antibody against peptidylarginine deiminase 4 by ELISA for rheumatoid arthritis.
     Clin Rheumatol. 2017 Sep 8. doi: 10.1007/s10067-017-3809.
     PubMed     Text format     Abstract available
     
     
     
227. MORI S, Yoshitama T, Hirakata N, Ueki Y, et al
     Prevalence of and factors associated with renal dysfunction in rheumatoid arthritis patients: a cross-sectional study in community hospitals.
     Clin Rheumatol. 2017 Sep 7. doi: 10.1007/s10067-017-3804.
     PubMed     Text format     Abstract available
     
     
     
228. AHLUWALIA V, Rampakakis E, Movahedi M, Cesta A, et al
     Predictors of patient decision to discontinue anti-rheumatic medication in patients with rheumatoid arthritis: results from the Ontario best practices research initiative.
     Clin Rheumatol. 2017 Sep 6. doi: 10.1007/s10067-017-3805.
     PubMed     Text format     Abstract available
     
     
     
229. GONG X, Xu SQ, Wu Y, Ma CC, et al
     Elevated serum 14-3-3eta protein may be helpful for diagnosis of early rheumatoid arthritis associated with secondary osteoporosis in Chinese population.
     Clin Rheumatol. 2017 Sep 5. doi: 10.1007/s10067-017-3807.
     PubMed     Text format     Abstract available
     
     
     
230. ZHANG F, Ma C
     Comparison of the effectiveness on intra-articular and subcutaneous TNF inhibitor in rheumatoid arthritis patients.
     Clin Rheumatol. 2017 Sep 4. doi: 10.1007/s10067-017-3806.
     PubMed     Text format     Abstract available
     
     
     August 2017
231. HAMMAM N, Gheita TA
     Impact of secondhand smoking on disease activity in women with rheumatoid arthritis.
     Clin Rheumatol. 2017 Aug 25. doi: 10.1007/s10067-017-3795.
     PubMed     Text format     Abstract available
     
     
     
232. SANTOS-MORENO P, Caballero-Uribe CV, Massardo ML, Maldonado CG, et al
     Systematic and progressive implementation of the centers of excellence for rheumatoid arthritis: a methodological proposal.
     Clin Rheumatol. 2017 Aug 24. doi: 10.1007/s10067-017-3790.
     PubMed     Text format     Abstract available
     
     
     
233. SUN X, Deng X, Geng Y, Ji L, et al
     A simplified and validated ultrasound scoring system to evaluate synovitis of bilateral wrists and hands in patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 Aug 22. doi: 10.1007/s10067-017-3785.
     PubMed     Text format     Abstract available
     
     
     
234. JEAN S, Hudson M, Gamache P, Bessette L, et al
     Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: a population-based study.
     Clin Rheumatol. 2017 Aug 21. doi: 10.1007/s10067-017-3796.
     PubMed     Text format     Abstract available
     
     
     
235. HATTORI Y, Kida D, Kaneko A
     Comparison of physical function in early rheumatoid arthritis patients treated with biologics for 1 year who achieved clinical remission or low disease activity.
     Clin Rheumatol. 2017 Aug 19. doi: 10.1007/s10067-017-3791.
     PubMed     Text format     Abstract available
     
     
     
236. D'AGOSTINO MA, Alten R, Mysler E, Le Bars M, et al
     Body mass index and clinical response to intravenous or subcutaneous abatacept in patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 Aug 18. doi: 10.1007/s10067-017-3788.
     PubMed     Text format     Abstract available
     
     
     
237. WANG B, Tang Y, Sun X, Ouyang X, et al
     Increased IL-6 expression on THP-1 by IL-34 stimulation up-regulated rheumatoid arthritis Th17 cells.
     Clin Rheumatol. 2017 Aug 15. doi: 10.1007/s10067-017-3746.
     PubMed     Text format     Abstract available
     
     
     
238. MUELLER RB, Graninger W, Sidiropoulos P, Goger C, et al
     Median time to low disease activity is shorter in tocilizumab combination therapy with csDMARDs as compared to tocilizumab monotherapy in patients with active rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: sub-analysi
     Clin Rheumatol. 2017 Aug 3. doi: 10.1007/s10067-017-3779.
     PubMed     Text format     Abstract available
     
     
     July 2017
239. GAUBITZ M, Gottl KH, Behmer O, Lippe R, et al
     Etanercept is effective as monotherapy or in combination with methotrexate in rheumatoid arthritis: subanalysis of an observational study.
     Clin Rheumatol. 2017 Jul 30. doi: 10.1007/s10067-017-3757.
     PubMed     Text format     Abstract available
     
     
     
240. JAHID M, Rehan-Ul-Haq, Jha PK, Chawla D, et al
     Tumor necrosis factor-alpha -308 polymorphism in North Indian rheumatoid arthritis patients and association with mRNA and serum TNF-alpha.
     Clin Rheumatol. 2017 Jul 27. doi: 10.1007/s10067-017-3774.
     PubMed     Text format     Abstract available
     
     
     
241. FENG ZT, Xu J, He GC, Cai SJ, et al
     A systemic review and meta-analysis of the clinical efficacy and safety of total glucosides of peony combined with methotrexate in rheumatoid arthritis.
     Clin Rheumatol. 2017 Jul 27. doi: 10.1007/s10067-017-3770.
     PubMed     Text format     Abstract available
     
     
     
242. PALAMAR D, Er G, Terlemez R, Ustun I, et al
     Disease activity, handgrip strengths, and hand dexterity in patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 Jul 18. doi: 10.1007/s10067-017-3756.
     PubMed     Text format     Abstract available
     
     
     
243. HARROLD LR, John A, Best J, Zlotnick S, et al
     Impact of rituximab on patient-reported outcomes in patients with rheumatoid arthritis from the US Corrona Registry.
     Clin Rheumatol. 2017 Jul 17. doi: 10.1007/s10067-017-3742.
     PubMed     Text format     Abstract available
     
     
     
244. WANG P, Li S, Liu LN, Lv TT, et al
     Circulating osteoprotegerin levels are elevated in rheumatoid arthritis: a systematic review and meta-analysis.
     Clin Rheumatol. 2017 Jul 11. doi: 10.1007/s10067-017-3747.
     PubMed     Text format     Abstract available
     
     
     
245. BOLETO G, Drame M, Lambrecht I, Eschard JP, et al
     Disease-modifying anti-rheumatic drug effect of denosumab on radiographic progression in rheumatoid arthritis: a systematic review of the literature.
     Clin Rheumatol. 2017 Jul 1. doi: 10.1007/s10067-017-3722.
     PubMed     Text format     Abstract available
     
     
     June 2017
246. HANNAWI S, AlSalmi I, Moller I, Naredo E, et al
     Uric acid is independent cardiovascular risk factor, as manifested by increased carotid intima-media thickness in rheumatoid arthritis patients.
     Clin Rheumatol. 2017 Jun 30. doi: 10.1007/s10067-017-3737.
     PubMed     Text format     Abstract available
     
     
     
247. BAPTISTA TSA, Petersen LE, Molina JK, de Nardi T, et al
     Autoantibodies against myelin sheath and S100beta are associated with cognitive dysfunction in patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 Jun 27. doi: 10.1007/s10067-017-3724.
     PubMed     Text format     Abstract available
     
     
     
248. BACALAO EJ, Greene GJ, Beaumont JL, Eisenstein A, et al
     Standardizing and personalizing the treat to target (T2T) approach for rheumatoid arthritis using the Patient-Reported Outcomes Measurement Information System (PROMIS): baseline findings on patient-centered treatment priorities.
     Clin Rheumatol. 2017 Jun 26. doi: 10.1007/s10067-017-3731.
     PubMed     Text format     Abstract available
     
     
     
249. HAN J, Geng Y, Deng X, Zhang Z, et al
     Risk factors of flare in rheumatoid arthritis patients with both clinical and ultrasonographic remission: a retrospective study from China.
     Clin Rheumatol. 2017 Jun 22. doi: 10.1007/s10067-017-3736.
     PubMed     Text format     Abstract available
     
     
     
250. SYNGLE A, Kaur S, Verma I, Syngle T, et al
     Cost-effective analysis of disease-modifying anti-rheumatic drugs in rheumatoid arthritis.
     Clin Rheumatol. 2017 Jun 21. doi: 10.1007/s10067-017-3725.
     PubMed     Text format     Abstract available
     
     
     
251. FASSIO A, Idolazzi L, Viapiana O, Benini C, et al
     In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls.
     Clin Rheumatol. 2017 Jun 20. doi: 10.1007/s10067-017-3734.
     PubMed     Text format     Abstract available
     
     
     
252. XIE X, Li F, Li S, Tian J, et al
     Application of omics in predicting anti-TNF efficacy in rheumatoid arthritis.
     Clin Rheumatol. 2017 Jun 10. doi: 10.1007/s10067-017-3639.
     PubMed     Text format     Abstract available
     
     
     
253. ROJAS-SERRANO J, Herrera-Bringas D, Perez-Roman DI, Perez-Dorame R, et al
     Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis.
     Clin Rheumatol. 2017 Jun 6. doi: 10.1007/s10067-017-3707.
     PubMed     Text format     Abstract available
     
     
     
254. SAG S, Sag MS, Tekeoglu I, Kamanli A, et al
     Nailfold videocapillaroscopy results in patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 Jun 4. doi: 10.1007/s10067-017-3696.
     PubMed     Text format     Abstract available
     
     
     
255. VOS I, Van Mol C, Trouw LA, Mahler M, et al
     Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays.
     Clin Rheumatol. 2017 Jun 3. doi: 10.1007/s10067-017-3684.
     PubMed     Text format     Abstract available
     
     
     
256. STOJANOVIC S, Bojana Stamenkovic, Stoimenov TJ, Nedovic J, et al
     Association of tumor necrosis factor-alpha (G-308A) genetic variant with matrix metalloproteinase-9 activity and joint destruction in early rheumatoid arthritis.
     Clin Rheumatol. 2017 Jun 1. doi: 10.1007/s10067-017-3699.
     PubMed     Text format     Abstract available
     
     
     May 2017
257. ROBUSTILLO-VILLARINO M, Alegre-Sancho JJ, Rodilla-Sala E, Corrales A, et al
     Pulse wave velocity and augmentation index are not independently associated with carotid atherosclerosis in patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 May 25. doi: 10.1007/s10067-017-3680.
     PubMed     Text format     Abstract available
     
     
     
258. JAUREGUI JJ, Paul Hovis J, Ashfaq Hasan S
     Characteristics of rheumatoid arthritis patients undergoing reverse shoulder arthroplasty.
     Clin Rheumatol. 2017 May 24. doi: 10.1007/s10067-017-3679.
     PubMed     Text format     Abstract available
     
     
     
259. EISSA M, El Shafey A, Hammad M
     Comparison between different disease activity scores in rheumatoid arthritis: an Egyptian multicenter study.
     Clin Rheumatol. 2017 May 22. doi: 10.1007/s10067-017-3674.
     PubMed     Text format     Abstract available
     
     
     
260. WANG X, Ma C, Li P, Zhao F, et al
     Effects of iguratimod on the levels of circulating regulators of bone remodeling and bone remodeling markers in patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 May 4. doi: 10.1007/s10067-017-3668.
     PubMed     Text format     Abstract available
     
     
     
261. STRAUB RH, Ehrenstein B, Gunther F, Rauch L, et al
     Increased extracellular water measured by bioimpedance and by increased serum levels of atrial natriuretic peptide in RA patients-signs of volume overload.
     Clin Rheumatol. 2017;36:1041-1051.
     PubMed     Text format     Abstract available
     
     
     April 2017
262. RAHNE T, Clauss F, Plontke SK, Keysser G, et al
     Prevalence of hearing impairment in patients with rheumatoid arthritis, granulomatosis with polyangiitis (GPA, Wegener's granulomatosis), or systemic lupus erythematosus.
     Clin Rheumatol. 2017 Apr 28. doi: 10.1007/s10067-017-3651.
     PubMed     Text format     Abstract available
     
     
     
263. SHIMIZU Y, Nakajima A, Inoue E, Shidara K, et al
     Characteristics and risk factors of lymphoproliferative disorders among patients with rheumatoid arthritis concurrently treated with methotrexate: a nested case-control study of the IORRA cohort.
     Clin Rheumatol. 2017 Apr 28. doi: 10.1007/s10067-017-3634.
     PubMed     Text format     Abstract available
     
     
     
264. ANYFANTI P, Triantafyllou A, Gkaliagkousi E, Triantafyllou G, et al
     Subendocardial viability ratio in patients with rheumatoid arthritis: comparison with healthy controls and identification of prognostic factors.
     Clin Rheumatol. 2017 Apr 28. doi: 10.1007/s10067-017-3659.
     PubMed     Text format     Abstract available
     
     
     
265. DONISAN T, Bojinca VC, Dobrin MA, Balanescu DV, et al
     The relationship between disease activity, quality of life, and personality types in rheumatoid arthritis and ankylosing spondylitis patients.
     Clin Rheumatol. 2017 Apr 27. doi: 10.1007/s10067-017-3654.
     PubMed     Text format     Abstract available
     
     
     
266. SON KM, Lee SY, Seo YI, Choi JE, et al
     Contribution of subjective Disease Activity Score 28 (DAS28) components to the response to treatment of rheumatoid arthritis.
     Clin Rheumatol. 2017 Apr 27. doi: 10.1007/s10067-017-3628.
     PubMed     Text format     Abstract available
     
     
     
267. EL-LEBEDY D, Raslan H, Ibrahim A, Ashmawy I, et al
     Association of STAT4 rs7574865 and PTPN22 rs2476601 polymorphisms with rheumatoid arthritis and non-systemically reacting antibodies in Egyptian patients.
     Clin Rheumatol. 2017 Apr 19. doi: 10.1007/s10067-017-3632.
     PubMed     Text format     Abstract available
     
     
     
268. TAKEUCHI H, Kawasaki T, Shigematsu K, Kawamura K, et al
     Neutrophil extracellular traps in neuropathy with anti-neutrophil cytoplasmic autoantibody-associated microscopic polyangiitis.
     Clin Rheumatol. 2017;36:913-917.
     PubMed     Text format     Abstract available
     
     
     March 2017
269. CUOMO G, D'Abrosca V, Iacono D, Pantano I, et al
     Erratum to: The conversion rate of tuberculosis screening tests during biological therapies in patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 Mar 28. doi: 10.1007/s10067-017-3614.
     PubMed     Text format    
     
     
     
270. MURALIDHARAN N, Misra DP, Jain VK, Negi VS, et al
     Effect of thymidylate synthase (TYMS) gene polymorphisms with methotrexate treatment outcome in south Indian Tamil patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 Mar 27. doi: 10.1007/s10067-017-3608.
     PubMed     Text format     Abstract available
     
     
     
271. RAMIREZ-PEREZ S, Salazar-Paramo M, Pineda-Monjaras S, De la Cruz-Mosso U, et al
     Association of 86 bp variable number of tandem repeat (VNTR) polymorphism of interleukin-1 receptor antagonist (IL1RN) with susceptibility and clinical activity in rheumatoid arthritis.
     Clin Rheumatol. 2017 Mar 25. doi: 10.1007/s10067-017-3610.
     PubMed     Text format     Abstract available
     
     
     
272. LI C, Wang XR, Ji HJ, Zhang XY, et al
     Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.
     Clin Rheumatol. 2017 Mar 24. doi: 10.1007/s10067-017-3596.
     PubMed     Text format     Abstract available
     
     
     February 2017
273. XIAO F
     Neuromyotonia as an unusual neurological complication of primary Sjogren's syndrome: case report and literature review.
     Clin Rheumatol. 2017;36:481-484.
     PubMed     Text format     Abstract available
     
     
     
274. CIPRIANI P, Berardicurti O, Masedu F, D'Onofrio F, et al
     Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study.
     Clin Rheumatol. 2017;36:251-260.
     PubMed     Text format     Abstract available
     
     
     
275. AKDEMIR G, Markusse IM, Goekoop-Ruiterman YP, Steup-Beekman GM, et al
     Rheumatologists' adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remission.
     Clin Rheumatol. 2017;36:317-326.
     PubMed     Text format     Abstract available
     
     
     January 2017
276. LIU C, Zhang H, Yao G, Hu Y, et al
     Characteristics of primary Sjogren's syndrome patients with IgG4 positive plasma cells infiltration in the labial salivary glands.
     Clin Rheumatol. 2017;36:83-88.
     PubMed     Text format     Abstract available
     
     
     
277. MUELLER RB, Reshiti N, Kaegi T, Finckh A, et al
     Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM).
     Clin Rheumatol. 2017;36:59-66.
     PubMed     Text format     Abstract available
     
     
     
278. ITO T, Tamura N, Okuda S, Tada K, et al
     Elevated serum levels of soluble CD146 in patients with systemic sclerosis.
     Clin Rheumatol. 2017;36:119-124.
     PubMed     Text format     Abstract available
     
     
     December 2016
279. KABEERDOSS J, Sandhya P, Mandal SK, Gowri M, et al
     High salivary soluble L-selectin and interleukin-7 levels in Asian Indian patients with primary Sjogren's syndrome.
     Clin Rheumatol. 2016;35:3063-3067.
     PubMed     Text format     Abstract available
     
     
     October 2016
280. TOZ B, Erer B
     Rheumatologic manifestations of primary immunodeficiency diseases: comment on the study by Dimitriades et al.
     Clin Rheumatol. 2016;35:2625.
     PubMed     Text format    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: